CDC’s Investments to Combat Antibiotic Resistance Threats: New York: Fiscal Year 2021

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  $8,748,571 Funding for AR Activities Fiscal year 2021
  
  One AR field staff & One local CDC AR experts
  
  Regional Lab for the AR Lab Network (Northeast)
  
  One of 10 sites for the Emerging Infections Program
  
  See CDC’s AR investments by state at www.cdc.gov/ARinvestments.
  
  Publication date from document properties.
  
  https://wwwn.cdc.gov/ARInvestments/PDFDocs/New-York-CDC-AR-Investments.pdf
  
  
• Subjects:
  Antimicrobial Stewardship Carbapenem-Resistant Enterobacteriaceae Communicable Diseases, Emerging Cross Infection/prevention & Control Drug Resistance, Microbial Financing, Government Food Safety Gonorrhea/prevention & Control Local Government Public Health State Government

  More +
• Series:
  Antibiotic Resistance (AR) Solutions in Action
• Document Type:
  Text
• Genre:
  Fact Sheet
• Place as Subject:
  New York
• Pages in Document:
  2 numbered pages
• Federal Fiscal Year:
  2021
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:c2a862b4b7abe6f91de380b6cf39f3550100a1d19996386bcb08754e76a2bd248b70fe5c4c6d542e8af7eb0f2ab871ae3be6aaf10b75c69be464c4ed707a24e2
• Download URL:
  https://stacks.cdc.gov/view/cdc/115750/cdc_115750_DS1.pdf
• File Type:
  [PDF - 439.56 KB ]